Amidst this evolving pandemic, doctors from Wuhan in China's Hubei Province, where the virus initially arose, have authored peer-reviewed research detailing eleven case reports they believe broadly represent COVID-19 disease at large.
Doctors in Wuhan have aggressively treated patients with antivirals not approved in the U.S. The drug they utilized most often was Arbidol, manufactured by the Russian company JSC Pharmstandard.
The antiviral drug Favipiravir, approved in Japan and China, could be more efficacious than Arbidol according to a sizable randomized clinical trial yet to be peer reviewed.
Given COVID-19's swift expansion, there should be plenty of opportunities to explore their potential.
The doctors presented the case of a 44-year-old man who beat back a mild course of COVID-19 in early February, was discharged from the hospital, then was readmitted two weeks later with an asymptomatic infection.
The coronavirus pandemic is still in its early stages and research is rapidly evolving as COVID-19 progresses.
Keep in mind that findings will fluctuate as more research is released.
https://www.realclearscience.com/quick_and_clear_science/2020/03/23/doctors_in_china_treated_covid-19_with_antivirals_not_approved_in_the_us.html
Doctors in Wuhan have aggressively treated patients with antivirals not approved in the U.S. The drug they utilized most often was Arbidol, manufactured by the Russian company JSC Pharmstandard.
The antiviral drug Favipiravir, approved in Japan and China, could be more efficacious than Arbidol according to a sizable randomized clinical trial yet to be peer reviewed.
Given COVID-19's swift expansion, there should be plenty of opportunities to explore their potential.
The doctors presented the case of a 44-year-old man who beat back a mild course of COVID-19 in early February, was discharged from the hospital, then was readmitted two weeks later with an asymptomatic infection.
The coronavirus pandemic is still in its early stages and research is rapidly evolving as COVID-19 progresses.
Keep in mind that findings will fluctuate as more research is released.
https://www.realclearscience.com/quick_and_clear_science/2020/03/23/doctors_in_china_treated_covid-19_with_antivirals_not_approved_in_the_us.html
No comments:
Post a Comment